KRISHNASWAMY GAJARAJ: Open Payments
NPI 1962488395 · RANDOLPH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 35 payments from 8 companies in 2025. Trend: 2023 $176 · 2024 $743 · 2025 $1,160
Food & beverage: $1,131Education: $29
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $403 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $188 |
| Vanda Pharmaceuticals Inc. | 11 | $186 |
| Janssen Pharmaceuticals, Inc | 1 | $136 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Lundbeck LLC | 3 | $74 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, FANAPT, INVEGA SUSTENNA, COBENFY, REXULTI, REJOYN, INGREZZA.
Industry payments across MA — which companies pay providers there.
